SCHEMBL8669208

SCHEMBL8669208

O=C(O)c1ccc([CH]Cc2ccc(C(=O)O)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.59
TP53 P04637 1/20 0.50
TSHR P16473 1/20 0.50
KMT2A Q03164 4/20 0.48
POLB P06746 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
GLA P06280 1/20 0.46
SRD5A2 P31213 3/20 0.44
CA12 O43570 2/20 0.43
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA3 P07451 2/20 0.43
CA4 P22748 2/20 0.43
CA6 P23280 2/20 0.43
CA5A P35218 2/20 0.43
CA7 P43166 2/20 0.43
CA9 Q16790 2/20 0.43
CA14 Q9ULX7 2/20 0.43
CA5B Q9Y2D0 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2185169 0.91 RXRA (0.53) ALDH1A1TP53TSHRKMT2APOLB
SCHEMBL1604682 0.80 ALDH1A1 (0.58) ALDH1A1TP53TSHRKMT2APOLB
SCHEMBL7519845 0.78 ALDH1A1 (0.64) ALDH1A1TP53TSHRKMT2APOLB
SCHEMBL2989613 0.78 ALDH1A1 (0.76) ALDH1A1TP53TSHRKMT2ASRD5A2
SCHEMBL28457429 0.77 LMNA (0.59) ALDH1A1KMT2AL3MBTL1GAAMAPT
SCHEMBL5197801 0.77 MAPT (0.51) ALDH1A1TP53TSHRKMT2APOLB
SCHEMBL714706 0.77 ALDH1A1 (0.54) ALDH1A1TP53TSHRKMT2APOLB
SCHEMBL5805280 0.75 ALDH1A1 (0.52) ALDH1A1TP53TSHRKMT2APOLB
Bicarbonate SCHEMBL9222817 0.75 ALDH1A1 (0.52) ALDH1A1TP53TSHRKMT2APOLB
SCHEMBL5576096 0.75 ALDH1A1 (0.52) ALDH1A1TP53TSHRKMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811422-A USEFUL FOR TREATING VIRAL INFECTIONS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-09-22 US disclosed
US-5610294-A VIRAL TREATMENT THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-11 US disclosed